A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-yr follow-up study

American Journal of Gastroenterology

Volumn 92, Issue 4, 1997, Pages 653-658

  Lerang, F ^a,b   Moum, B ^a   Ragnhildstveit, E ^a   Haug, J B ^a   Hauge, T ^a   Tolas P ^a   Aubert, E ^a   Henriksen, M ^a   Efskind, P S ^a   Nicolaysen, K ^a   Soberg T ^a   Odegaard A ^a   Berge, T ^a  

^a Østfold Central Hospital   (Norway)

^b Østfold Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; METRONIDAZOLE; OMEPRAZOLE; OXYTETRACYCLINE;

ABDOMINAL DISCOMFORT; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH BIOPSY; TASTE AVERSION; TREATMENT OUTCOME;

ADULT; AGED; AMOXICILLIN; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; OXYTETRACYCLINE; PENICILLINS; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS;

EID: 0030891435     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chiba N, Rao BV, Radaemaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
2. Penston JG. Helicobacter pylori eradication: Understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:369-89.
3. Wilhelmsen I, Weberg R, Berstad K, et al. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepatogastroenterology 1994;41: 43-7.
4. Tytgat GJN. Review article: Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
5. Bell GD, Powell K, Burridge SM, et al. Experience with "triple" anti-Helicobacter pylori eradication therapy: Side effects and importance of testing the pretreatment isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-35.
6. Logan RPH, Gummett PA, Misiewicz JJ, et al. One week's anti-Helicobacter pylori treatment for duodenal ulcer. Gut 1994;35:15-8.
7. Rautelin H, Seppala K, Renkonen OV, et al. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992;36:163-6.
8. Burette A, Glupczynski Y, De Prez C. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:817-23.
9. Borody T, Andrews P, Brandi S, et al. Relevance of in-vitro metronidazole resistance to H. pylori (HP) eradication and eradication failure. Gastroenterology 1993;104:A44.
10. Grahams DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
11. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993;88:505-9.
12. de Boer WA, Driessen WM, Potters HV, et al. Randomized study comparing one with two weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993-7.
13. Borody TJ, Brandl S, Andrews P, et al. Use of high efficacy, low dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:33-8.
14. Hentschel B, Brandstatter G, Dragosica D, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of H. pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
15. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxicillin and metronidazole compared with four alternative regimens. Q J Med 1993;86:743-50.
16. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-6.
17. Powell KU, Bell GD, Bowden AF, et al. Helicobacter pylori eradication therapy: A comparison between either omeprazole or ranitidine in combination with amoxicillin plus metronidazole. Br J Clin Res 1995; 6:163-9.
18. de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
19. Walters LL, Budin RE, Paull G. Acridine-orange to identify Campylobacter pyloridis in formalin fixed, paraffin-embedded gastric biopsies. Lancet 1986;1:42.
20. Kosunen T, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titers after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
21. Hirschl AM, Branstatter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993;168:763-6.
22. Saberi-Firoozi M, Massarat S, Zare S, et al. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: A prospective, randomized, controlled study. Am J Gastroenterol 1995; 90:1419-23.
23. Xia H, Daw MA, Sant S, et al. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993;5:141-4.
24. Noach LA, Bertola MA, Schwarts MP, et al. Treatment of Helicobacter pylori infection: An evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994;6:585-91.
25. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrobial Chemother 1993;32:45-9.
26. Cederbrant G, Kahlmeter G, Ljungh Å. Proposed mechanism for metronidazole resistance in Helicobacter pylori J Antimicrobial Chemother 1992;29:115-20.
27. van Zwet AA, Thijs JC de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995;39:250-2.
28. van Caekenberghe DI, Breyssens J. In vitro synergistic activity between bismuth subcitrate and various antimicobial agents against Campylobacter pyloridis (C. pylori). Antimicrobial Agents Chemother 1987;31:1429-30.
29. Thijs JC, Van Zwet AA, Oey HB. Efficacy and side effects of a triple therapy regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993;28:934-8.
30. de Boer WA, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345:817-20.
31. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: A randomised controlled trial. Lancet 1994;343:508-10.
32. Brown KE, Peura DA. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:105-15.
33. van Zwet AA, Thijs JC, Kooistra-Smid AM, et al. Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antra1 biopsy samples. J Clin Microbiol 1993;31:1918-20.
34. Cutler AF, Havstad S, Ma CH, et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.
35. Siepman N, Green R, Aynilian G. A comparison of biopsy specimens from the antrum and corpus for culture of H. pylori. Gut 1995;37(suppl 2):A81.
36. Labenz J, Tillenburg B, Peitz U, et al. Long-term clinical course of ulcer disease and incidence of reflux eosophagitis in a large cohort of duodenal ulcer patients followed after eradication of Helicobacter pylori. Gut 1995;37(suppl 1):A6.